BeyondSpring Inc. Form 20-F: Annual report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2024-04-29: Form 20-F; Period of report 2023-12-31; Description FORM 20-F; Document bysi20231231_20f.htm.
- 2023-04-18: Form 20-F; Period of report 2022-12-31; Description FORM 20-F; Document bysi20221230_20f.htm.
- 2022-04-14: Form 20-F; Period of report 2021-12-31; Description FORM 20-F; Document bysi20211231_20f.htm.
- 2021-04-30: Form 20-F; Period of report 2020-12-31; Description 20-F; Document brhc10020618_20f.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2024-04-29 | 20-F | 2023-12-31 | FORM 20-F | bysi20231231_20f.htm |
| 2023-04-18 | 20-F | 2022-12-31 | FORM 20-F | bysi20221230_20f.htm |
| 2022-04-14 | 20-F | 2021-12-31 | FORM 20-F | bysi20211231_20f.htm |
| 2021-04-30 | 20-F | 2020-12-31 | 20-F | brhc10020618_20f.htm |
| 2020-04-30 | 20-F | 2019-12-31 | 20-F | form20f.htm |
| 2019-04-30 | 20-F | 2018-12-31 | 20-F | form20f.htm |
| 2018-04-03 | 20-F | 2017-12-31 | 20-F | form20f.htm |
| 2017-04-28 | 20-F | 2016-12-31 | FORM 20-F | s001637x1_form20-f.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |